메뉴 건너뛰기




Volumn 119, Issue 17, 2012, Pages 3869-3870

Get out - and stay out

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYTARABINE; ETOPOSIDE; MITOXANTRONE; PLACEBO; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1ALPHA;

EID: 84860319398     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-410357     Document Type: Note
Times cited : (1)

References (10)
  • 1
    • 84860349448 scopus 로고    scopus 로고
    • Aphase 1/2 study of chemosensitization with the CXCR4 antagonist plerixa for in relapsed or refractory acute myeloid leukemia
    • Uy GL, Rettig MP, Motabi IH, et al. Aphase 1/2 study of chemosensitization with the CXCR4 antagonist plerixa for in relapsed or refractory acute myeloid leukemia. Blood. 2012;119(17):3917-3924.
    • (2012) Blood , vol.119 , Issue.17 , pp. 3917-3924
    • Uy, G.L.1    Rettig, M.P.2    Motabi, I.H.3
  • 2
    • 0033524834 scopus 로고    scopus 로고
    • Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
    • Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283(5403):845-848.
    • (1999) Science , vol.283 , Issue.5403 , pp. 845-848
    • Peled, A.1    Petit, I.2    Kollet, O.3
  • 4
    • 0037777665 scopus 로고    scopus 로고
    • Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells
    • Christopherson KW 2nd, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood. 2003; 101(12):4680-4686. (Pubitemid 36857720)
    • (2003) Blood , vol.101 , Issue.12 , pp. 4680-4686
    • Christopherson II, K.W.1    Cooper, S.2    Broxmeyer, H.E.3
  • 6
    • 67650367598 scopus 로고    scopus 로고
    • Targeting the leukemia microenvironment byCXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
    • Zeng Z, Shi YX, Samudio IJ, et al. Targeting the leukemia microenvironment byCXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood. 2009;113(24):6215-6224.
    • (2009) Blood , vol.113 , Issue.24 , pp. 6215-6224
    • Zeng, Z.1    Shi, Y.X.2    Samudio, I.J.3
  • 7
    • 57849163583 scopus 로고    scopus 로고
    • The CXCR4 antagonist AMD3100 impairs survivalofhuman AML cells and induces their differentiation
    • Tavor S, Eisenbach M, Jacob-Hirsch J, et al. The CXCR4 antagonist AMD3100 impairs survivalofhuman AML cells and induces their differentiation. Leukemia. 2008;22(12):2151-5158.
    • (2008) Leukemia , vol.22 , Issue.12 , pp. 2151-5158
    • Tavor, S.1    Eisenbach, M.2    Jacob-Hirsch, J.3
  • 8
    • 67650410440 scopus 로고    scopus 로고
    • Chemosensitization of acute myeloid leukemia (AML) following mobilization bythe CXCR4 antagonist AMD3100
    • Nervi B, Ramirez P, Rettig MP, et al. Chemosensitization of acute myeloid leukemia (AML) following mobilization bythe CXCR4 antagonist AMD3100. Blood. 2009; 113(24):6206-6214.
    • (2009) Blood , vol.113 , Issue.24 , pp. 6206-6214
    • Nervi, B.1    Ramirez, P.2    Rettig, M.P.3
  • 10
    • 33846241600 scopus 로고    scopus 로고
    • CXCR4 is a prognostic marker in acute myelogenous leukemia
    • DOI 10.1182/blood-2006-05-024844
    • Spoo AC, Lubbert M, Wierda WG, Burger JA. CXCR4 is a prognostic marker in acute myelogenous leukemia. Blood. 2007;109(2):786-791. (Pubitemid 46105982)
    • (2007) Blood , vol.109 , Issue.2 , pp. 786-791
    • Spoo, A.C.1    Lubbert, M.2    Wierda, W.G.3    Burger, J.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.